EAM Investors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Buy |
+334,347
| New | +$3M | 0.45% | 108 |
|
|
2022
Q2 | – | Sell |
-162,969
| Closed | -$2.65M | – | 255 |
|
|
2022
Q1 | $2.65M | Buy |
+162,969
| New | +$2.65M | 0.49% | 63 |
|
|
2021
Q4 | – | Sell |
-163,324
| Closed | -$2.35M | – | 292 |
|
|
2021
Q3 | $2.35M | Sell |
163,324
-86,532
| -35% | -$1.24M | 0.4% | 80 |
|
|
2021
Q2 | $3.95M | Buy |
+249,856
| New | +$3.95M | 0.61% | 22 |
|
|
2020
Q3 | – | Sell |
-563,961
| Closed | -$2.69M | – | 283 |
|
|
2020
Q2 | $2.69M | Buy |
+563,961
| New | +$2.69M | 0.59% | 40 |
|
|
2019
Q2 | – | Sell |
-287,805
| Closed | -$2.34M | – | 256 |
|
|
2019
Q1 | $2.34M | Sell |
287,805
-16,472
| -5% | -$134K | 0.57% | 47 |
|
|
2018
Q4 | $2.46M | Buy |
+304,277
| New | +$2.46M | 0.67% | 30 |
|
|
2017
Q2 | – | Sell |
-109,625
| Closed | -$921K | – | 296 |
|
|
2017
Q1 | $921K | Buy |
+109,625
| New | +$921K | 0.15% | 201 |
|
|
2015
Q4 | – | Sell |
-89,061
| Closed | -$1.02M | – | 312 |
|
|
2015
Q3 | $1.02M | Sell |
89,061
-27,908
| -24% | -$318K | 0.16% | 261 |
|
|
2015
Q2 | $1.75M | Buy |
+116,969
| New | +$1.75M | 0.2% | 200 |
|
|
2014
Q4 | – | Sell |
-85,721
| Closed | -$838K | – | 314 |
|
|
2014
Q3 | $838K | Hold |
85,721
| – | – | 0.17% | 287 |
|
|
2014
Q2 | $1.09M | Sell |
85,721
-28,827
| -25% | -$368K | 0.21% | 275 |
|
|
2014
Q1 | $1.21M | Buy |
+114,548
| New | +$1.21M | 0.22% | 255 |
|
|
2013
Q4 | – | Sell |
-148,081
| Closed | -$1.08M | – | 311 |
|
|
2013
Q3 | $1.08M | Buy |
+148,081
| New | +$1.08M | 0.22% | 238 |
|